Torrent Pharmaceuticals Q2 FY27 Investor Conference Call

Event Type: Post Quarterly Financial Result Conference call with investors/analysts
Event Date and Time: 23rd October, 2026 at 05:30 P.M. (Indian Standard Time)
Purpose: To discuss the financial performance of the Company for the quarter and half year ended 30th September, 2026
Timing Relative to Earnings: Scheduled after the financial results announcement for Q2 and H1 FY27
Management Participants: Not specified in the disclosure
Materials Availability: No specific mention of presentation decks, transcripts, or recordings being made available
UPSI Statement: The disclosure does not include any explicit statement regarding unpublished price sensitive information, suggesting standard compliance protocol

The conference call will specifically address financial performance for:

Dial-in Information: Extensive global dial-in numbers provided for India National Toll Free (1 800 120 1221), Universal dial-in (+91 22 6280 1439, +91 22 7115 8803), and international toll-free numbers for multiple countries including Argentina, Australia, Belgium, Canada, China, France, Germany, Hong Kong, Italy, Japan, Netherlands, Poland, Singapore, South Korea, Sweden, Thailand, UK, and USA
Registration: Diamond Pass registration link provided: https://services.choruscall.in/DiamondPassRegistration/register?confirmationNumber=0173484&linkSecurityString=1846085f4
Attachments: No attachments mentioned in the disclosure
Financial Data Disclosure: No actual financial figures or performance data were disclosed in this announcement
Compliance: Signed by CHINTAN M. TRIVEDI, COMPANY SECRETARY, with digital signature timestamp: 2026.10.09 10:11:54 +05'30'